BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoo SY, Badrinath N, Lee HL, Heo J, Kang DH. A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma. Cancers (Basel) 2019;11:E1667. [PMID: 31717883 DOI: 10.3390/cancers11111667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Ailia MJ, Yoo SY. In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review. Vaccines (Basel) 2022;10:1541. [PMID: 36146619 DOI: 10.3390/vaccines10091541] [Reference Citation Analysis]
2 Yoo SY, Badrinath N, Jeong SN, Woo HY, Heo J. Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment. Vaccines (Basel) 2020;8:E321. [PMID: 32575351 DOI: 10.3390/vaccines8020321] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
3 Jeong SN, Yoo SY. Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity. Cancers (Basel) 2020;12:E1070. [PMID: 32344903 DOI: 10.3390/cancers12051070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]